Codeine o-demethylation: Rat strain differences and the effects of inhibitors
- 1 March 1991
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 41 (5) , 757-762
- https://doi.org/10.1016/0006-2952(91)90077-i
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI)Published by Elsevier ,2005
- Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers.British Journal of Clinical Pharmacology, 1991
- The genetic polymorphism of debrisoquine/sparteine metabolism — Clinical aspectsPharmacology & Therapeutics, 1990
- Codeine O‐demethylation co‐segregates with polymorphic debrisoquine hydroxylation.British Journal of Clinical Pharmacology, 1989
- POLYMORPHIC O-DEMETHYLATION OF CODEINEThe Lancet, 1988
- In-vivo and in-vitro dextromethorphan metabolism in SD and DA ratBiochemical Pharmacology, 1988
- Characterization of the common genetic defect in humans deficient in debrisoquine metabolismNature, 1988
- Bufuralol 1'-hydroxylase activity of the ratBiochemical Pharmacology, 1986
- Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strainsJournal of Pharmacy and Pharmacology, 1981
- The Metabolism of Morphine and Heroin in ManDrug Metabolism Reviews, 1975